The strategic investment from Oak HC/FT and Cedars-Sinai Health Ventures will support the rapid expansion of Regard's AI-powered clinical insights platform, designed to unlock the power of the EHR.
respect, AI-powered The company, a clinical insights platform that enables clinicians to unlock the full potential of patient data, today announced $61 million The Series B funding round was led by Oak HC/FT, with participation from Cedars-Sinai Health Ventures, as well as existing investors TenOneTen Ventures, Calibrate Ventures and Techstars. The investment will enable the company to accelerate product development with its core clinical insights platform, invest in foundational research into large-scale language models (LLMs) and expand beyond inpatient facilities.
Read also: AMD Acquires Silo AI, Expanding Enterprise AI Solutions Globally
“Regard is positioned to revolutionize the way physicians think about clinical decision support.” Nancy BrownGeneral Partner at Oak HC/FT. “Regard's team has built a platform that delivers value to patients, physicians, and health systems alike by improving outcomes, increasing efficiency, reducing burnout, and increasing revenue. Eli and Nate are thoughtful about product development, and we are excited to be part of this next chapter as they aim to deliver this value at scale.”
The influx of new technologies is generating more medical data than ever before, but much of it remains untapped for clinical care. According to the World Economic Forum, physicians are using less than 3% of available patient data. With an average of 50,000 data points per patient, there is a huge gap between the vast amount of data available and the clinically actionable insights generated from it. Regard bridges the clinical insight gap by analyzing all available data and recommending diagnoses, empowering clinicians to deliver better care. Once the clinician reviews and approves the recommendation, Regard ensures complete and accurate documentation in a standardized format, a critical step to ensure clinical quality and improve hospital revenue.
“Cedars-Sinai has worked with Regard since the beginning because they saw a strong need to provide physicians with data that can provide critical analytics and insights to aid in diagnosis and treatment,” he said. Maureen Burgess“More importantly, we believe it will improve patient care and the patient experience,” said Mike S., partner at Cedars-Sinai Health Ventures.
Read also: Security Compass Expands Industry-Leading AI Security Content and Introduces AI-Powered Navigator Beta
Since its launch in 2021, Regard's technology has provided medical teams with more than 3 million diagnostic results, $50 million It helps drive incremental revenue for its enterprise health system partners such as Banner Health and Sentara, and recently announced a partnership with WakeMed Health & Hospitals, a leading health system in India. Raleigh, North Carolina.
“Imagine if physicians could see all the electronic medical record information they need about their patient right in front of them in just seconds. Regard analyzes vast amounts of clinical data and provides clinicians with potential diagnostic and treatment recommendations, enhancing patient care and impacting the quality and safety of care in real time,” said Regard. Eli Ben Joseph“This is a milestone,” said the Regard CEO, “not just for doctors, but for the people whose lives are in their hands.”
Read also: Survey finds only 20% of senior IT leaders are using generative AI in production
[To share your insights with us as part of editorial or sponsored content, please write to psen@itechseries.com]
